Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation |
Lim, Ji-Young
(Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea)
Ryu, Da-Bin (Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea) Lee, Sung-Eun (Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea) Park, Gyeongsin (Department of Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea) Choi, Eun Young (Department of Biomedical Sciences, Seoul National University College of Medicine) Min, Chang-Ki (Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea) |
1 | Appelbaum, F.R. (2001). Haematopoietic cell transplantation as immunotherapy. Nature 411, 385-389. DOI |
2 | Asprodites, N., Zheng, L., Geng, D., Velasco-Gonzalez, C., Sanchez-Perez, L., and Davila, E. (2008). Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J. 22, 3628-3637. DOI |
3 | Barrett, A.J. (1997). Mechanisms of the graft-versus-leukemia reaction. Stem Cells 15, 248-258. DOI |
4 | Bendigs, S., Salzer, U., Lipford, G.B., Wagner, H., and Heeg, K. (1999). CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 29, 1209-1218. DOI |
5 | Caron, G., Duluc, D., Fremaux, I., Jeannin, P., David, C., Gascan, H., and Delneste, Y. (2005). Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175, 1551-1557. DOI |
6 | Chang, J., Burkett, P.R., Borges, C.M., Kuchroo, V.K., Turka, L.A., and Chang, C.H. (2013). MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc. Natl. Acad. Sci. USA 110, 2270-2275. DOI |
7 | Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., Jr., and Ferrara, J.L. (1998). Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102, 1882-1891. DOI |
8 | Cottalorda, A., Verschelde, C., Marcais, A., Tomkowiak, M., Musette, P., Uematsu, S., Akira, S., Marvel, J., and Bonnefoy-Berard, N. (2006). TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 36, 1684-1693. DOI |
9 | Dudley, M.E., Wunderlich, J.R., Yang, J.C., Sherry, R.M., Topalian, S.L., Restifo, N.P., Royal, R.E., Kammula, U., White, D.E., Mavroukakis, S.A., et al. (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346-2357. DOI |
10 | Fukata, M., Breglio, K., Chen, A., Vamadevan, A.S., Goo, T., Hsu, D., Conduah, D., Xu, R., and Abreu, M.T. (2008). The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 180, 1886-1894. DOI |
11 | Gelman, A.E., Zhang, J., Choi, Y., and Turka, L.A. (2004). Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172, 6065-6073. DOI |
12 | Hartman, Z.C., Osada, T., Glass, O., Yang, X.Y., Lei, G.J., Lyerly, H.K., and Clay, T.M. (2010). Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. Cancer Res. 70, 7209-7220. DOI |
13 | Hill, G.R., and Ferrara, J.L. (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95, 2754-2759. |
14 | Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., et al. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562. |
15 | Lim, J.Y., Cho, B.S., Min, C.K., Park, G., Kim, Y.J., Chung, N.G., Jeong, D.C., and Min, W.S. (2014). Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol. Invest. 43, 41-53. DOI |
16 | Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999). Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122. DOI |
17 | Komai-Koma, M., Jones, L., Ogg, G.S., Xu, D., Liew, F.Y. (2004). TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101, 3029-3034. DOI |
18 | Lim, J.Y., Choi, M.S., Youn, H., Choi, E.Y., and Min, C.K. (2011). The influence of pretransplantation conditioning on graft-vs.-leukemia effect in mice. Exp. Hematol. 39, 1018-1029. DOI |
19 | Min, C.K., Maeda, Y., Lowler, K., Liu, C., Clouthier, S., Lofthus, D., Weisiger, E., Ferrara, J.L., and Reddy, P. (2004). Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood 104, 3393-3399. DOI |
20 | Schmaltz, C., Alpdogan, O., Horndasch, K.J., Muriglan, S.J., Kappel, B.J., Teshima, T., Ferrara, J.L., Burakoff, S.J., and van den Brink, M.R. (2001). Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97, 2886-2895. DOI |
21 | Schmaltz, C., Alpdogan, O., Muriglan, S.J., Kappel, B.J., Rotolo, J.A., Ricchetti, E.T., Greenberg, A.S., Willis, L.M., Murphy, G.F., Crawford, J.M., et al. (2003). Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101, 2440-2445. DOI |
22 | Teshima, T., Hill, G.R., Pan, L., Brinson, Y.S., van den Brink, M.R., Cooke, K.R., and Ferrara, J.L. (1999). IL-11 separates graft-versus- leukemia effects from graft-versus-host disease after bone marrow transplantation. J. Clin. Invest. 104, 317-325. DOI |
23 | Schnare, M., Barton, G.M., Holt, A.C., Takeda, K., Akira, S., and Medzhitov, R. (2001). Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950. DOI |
24 | Shin, H.J., Baker, J., Leveson-Gower, D.B., Smith, A.T., Sega, E.I., and Negrin, R.S. (2011). Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118, 2342-2350. DOI |
25 | Taylor, P.A., Lees, C.J., and Blazar, B.R. (2002). The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499. DOI |
26 | Tomita, T., Kanai, T., Fujii, T., Nemoto, Y., Okamoto, R., Tsuchiya, K., Totsuka, T., Sakamoto, N., Akira, S., and Watanabe, M. (2008). MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J. Immunol. 180, 5291-5299. DOI |
27 | van den Brink, M.R., and Burakoff, S.J. (2002). Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2, 273-281. DOI |
28 | Wu, H., Chen, G., Wyburn, K.R., Yin, J., Bertolino, P., Eris, J.M., Alexander, S.I., Sharland, A.F., and Chadban, S.J. (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859. DOI |
29 | Wysocki, C. A., Panoskaltsis-Mortari, A., Blazar, B. R., and Serody, J. S. (2005). Leukocyte migration and graft-versus-host disease. Blood 105, 4191-4199. DOI |
30 | Yang, Y.G., Sergio, J.J., Pearson, D.A., Szot, G.L., Shimizu, A., and Sykes, M. (1997). Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 90, 4651-4660. |
31 | Yang, Y.G., Qi, J., Wang, M.G., and Sykes, M. (2002). Donorderived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99, 4207-4215. DOI |
32 | Zheng, L., Asprodites, N., Keene, A.H., Rodriguez, P., Brown, K.D., and Davila, E. (2008). TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements. Blood 111, 2704-2713. DOI |
![]() |